Toyobo Co., Ltd. (3101) cut its full-year net profit forecast by 42.9% to ¥4.0 billion after booking a ¥6.5 billion impairment loss on its pharmaceutical contract manufacturing business, while raising its operating profit outlook to ¥27.0 billion from ¥23.0 billion.
The company said contract volumes at the pharmaceutical unit fell as competing products emerged, and after reviewing its business plan it wrote the unit's assets down to their recoverable value in the second quarter. Solid sales of release film for ceramic capacitors and Cosmoshine SRF polarizer protective film lifted the sales and profit outlook.
| Item | Previous | Revised |
|---|---|---|
| Net sales | ¥435.0 billion | ¥440.0 billion |
| Operating profit | ¥23.0 billion | ¥27.0 billion |
| Ordinary profit | ¥18.5 billion | ¥22.1 billion |
| Net profit | ¥7.0 billion | ¥4.0 billion |
For the April-September first half, net sales rose 7.1% to ¥218.459 billion and operating profit climbed 37.9% to ¥16.259 billion, while net profit fell 40.6% to ¥3.405 billion. The life science segment posted an operating loss of ¥1.6 billion, versus a ¥100 million profit a year earlier. The year-end dividend forecast was kept at ¥40 per share.
Separately, Toyobo booked ¥500 million in retirement-related costs tied to the suspension of El Salvador subsidiary INDUSTRIAS UNIDAS, S.A. (IUSA), and a ¥1.3 billion gain on the first handover of IUSA fixed assets. The impact on the full-year forecast is still under review.
Next steps: Toyobo plans to file its semiannual report on Nov. 11, 2026. Further IUSA suspension costs are expected from the third quarter, and the second asset handover is scheduled for May 2027, with the gain to be booked in the first quarter of the fiscal year ending March 2028.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。